BA
42
4
AMG
75
-7
AMT
37
-2
DAL
70
-3
BBY
45
-4
AN
52
-13
AIZ
59
-2
CHRW
73
-4
CCL
65
-3
AA
67
-5
EMC
60
-12
CMI
72
-5
CMG
54
4
AVGO
38
-25
AES
55
-3
CMCSA
42
8
EQIX
50
-3
ADSK
58
-4
BLK
61
-5
EMN
62
-3
BA
42
4
AMG
75
-7
AMT
37
-2
DAL
70
-3
BBY
45
-4
AN
52
-13
AIZ
59
-2
CHRW
73
-4
CCL
65
-3
AA
67
-5
EMC
60
-12
CMI
72
-5
CMG
54
4
AVGO
38
-25
AES
55
-3
CMCSA
42
8
EQIX
50
-3
ADSK
58
-4
BLK
61
-5
EMN
62
-3
Financhill
Back

Cleveland-Cliffs, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
39

CLF
Cleveland-Cliffs, Inc.

Last Price:
$12.71
Seasonality Move:
6.63%
Buy
77

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.65
Seasonality Move:
9.28%
Sell
39
Cleveland-Cliffs, Inc. (CLF) is a Sell

Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?

  • The current Cleveland-Cliffs, Inc. [CLF] share price is $12.71. The Score for CLF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLF Stock Price Chart

What is Cleveland-Cliffs, Inc.'s stock price today?

  • The Cleveland-Cliffs, Inc. share price today is $12.71
    The current trend is moderately bullish and CLF is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 54.21 Buy
Chaikin Money Flow: -12267118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.85 - 12.85) Buy
Bollinger Bands (100): (10.36 - 13.04) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.57 Buy
Relative Strength Index (14 RSI): 86.06 Buy
Chaikin Money Flow: 367727 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (151.4 - 242.46) Buy
Bollinger Bands (100): (51.44 - 167.06) Buy

CLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.71 Buy
20-day SMA: 12.19 Buy
50-day SMA: 12.46 Buy
200-day SMA: 9.96 Buy
8-day EMA: 12.71 Sell
20-day EMA: 12.39 Buy
50-day EMA: 12.11 Buy
200-day EMA: 11.16 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.33 Buy
20-day SMA: 219.69 Buy
50-day SMA: 150.04 Buy
200-day SMA: 68.84 Buy
8-day EMA: 219.45 Buy
20-day EMA: 204.15 Buy
50-day EMA: 162.92 Buy
200-day EMA: 88.08 Buy

Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $2.71 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Cleveland-Cliffs, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):